Key Takeaways: - The oral microbiome plays a significant role in the severity of oral mucositis (OM) in patients with head and neck cancer undergoing chemotherapy and radiotherapy. - The study found that specific microbial features, such as certain bacteria, were associated with the progression of OM. - The findings suggest the potential for personalized treatment plans targeting the oral microbiome to prevent and treat oral mucositis.
Summary: A recent study conducted at The University of Texas MD Anderson Cancer Centre reveals that the oral microbiome is linked to the severity of oral mucositis (OM) in patients with head and neck cancer undergoing chemotherapy and radiotherapy. OM is a common side effect experienced by nearly all patients with head and neck cancer and can cause significant discomfort. The study analyzed 142 adult patients and found that certain microbial features,…
